|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
ocn709890793 |
003 |
OCoLC |
005 |
20241120213016.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
110330s2009 nyua ob 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d OCLCQ
|d YDXCP
|d E7B
|d OCLCF
|d OCLCQ
|d NLGGC
|d OCLCO
|d OCLCQ
|d OCLCO
|d EBLCP
|d OCLCO
|d OCLCQ
|d OCLCO
|d AZK
|d OCLCO
|d MERUC
|d AGLDB
|d MOR
|d PIFAG
|d ZCU
|d OCLCQ
|d U3W
|d STF
|d WRM
|d VTS
|d COCUF
|d NRAMU
|d ICG
|d VT2
|d AU@
|d OCLCQ
|d WYU
|d DKC
|d OCLCQ
|d UKCRE
|d BOL
|d M8D
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCL
|
019 |
|
|
|a 923660255
|a 961551553
|a 962686265
|a 988439038
|a 991923734
|a 1037943117
|a 1038657491
|a 1045502022
|a 1055358023
|a 1065672648
|a 1081205761
|a 1114352450
|a 1153460051
|a 1228554471
|a 1354624369
|
020 |
|
|
|a 9781612098531
|q (electronic bk.)
|
020 |
|
|
|a 1612098533
|q (electronic bk.)
|
020 |
|
|
|z 9781606920534
|
020 |
|
|
|z 1606920537
|
035 |
|
|
|a (OCoLC)709890793
|z (OCoLC)923660255
|z (OCoLC)961551553
|z (OCoLC)962686265
|z (OCoLC)988439038
|z (OCoLC)991923734
|z (OCoLC)1037943117
|z (OCoLC)1038657491
|z (OCoLC)1045502022
|z (OCoLC)1055358023
|z (OCoLC)1065672648
|z (OCoLC)1081205761
|z (OCoLC)1114352450
|z (OCoLC)1153460051
|z (OCoLC)1228554471
|z (OCoLC)1354624369
|
050 |
|
4 |
|a RA1231.A8
|b A83 2009eb
|
072 |
|
7 |
|a MED
|x 096000
|2 bisacsh
|
049 |
|
|
|a HCDD
|
245 |
0 |
0 |
|a Asbestos :
|b risks, environment and impact /
|c Antonio Soto and Gael Salazar, editors.
|
260 |
|
|
|a New York :
|b Nova Biomedical Books,
|c ©2009.
|
300 |
|
|
|a 1 online resource (xii, 211 pages) :
|b illustrations (some color)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
340 |
|
|
|g polychrome.
|2 rdacc
|0 http://rdaregistry.info/termList/RDAColourContent/1003
|
347 |
|
|
|a text file
|2 rdaft
|0 http://rdaregistry.info/termList/fileType/1002
|
490 |
1 |
|
|a Environmental Health - Physical, Chemical and Biological Factors
|
504 |
|
|
|a Includes bibliographical references and index.
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a ASBESTOS: RISKS, ENVIRONMENT AND IMPACT -- CONTENTS -- PREFACE -- DEPOSITION OF MAN-MADE FIBERS IN THE HUMANRESPIRATORY AIRWAY -- ABSTRACT -- 1.1. INTRODUCTION -- 1.2. EXPERIMENTAL METHOD -- 1.2.1. Human Nasal Airway Cast -- 1.2.2. Human Respiratory Airway Casts -- 1.2.3. Fiber Materials -- 1.2.4. Experimental Setup -- 1.2.5. Sample Preparation, Fiber Counting, and Length Measurement -- 1.3. RESULTS AND DISCUSSION -- 1.3.1. Fiber Deposition in the Human Nasal Airway -- 1.3.2. Fiber Deposition Efficiency in the Human Nasal Airway -- 1.3.3. Comparison of Nasal Deposition between Fibers and Compact Particles -- 1.3.4. Empirical Model for Fiber Deposition in the Nasal Airway -- 1.3.5. Fiber Deposition in the Human Oral Airway -- 1.3.6. Fiber Deposition Pattern in the Human Respiratory Airway -- 1.3.7. Fiber Deposition in the Tracheobronchial Airways -- 1.3.8. Comparison of Fiber Deposition in the Human Airways -- 1.4. CONCLUSION -- REFERENCES -- NUMBER OF PLASMIDS TRANSPORTED INTOESCHERICHIA COLI THROUGH THE YOSHIDA EFFECTAND PREDICTED STRUCTURE OF THEPENETRATION-INTERMEDIATE -- ABSTRACT -- INTRODUCTION -- MATERIALS AND METHODS -- E. COLI STRAIN AND PLASMIDS -- PREPARATION OF THE CHRYSOTILE COLLOIDAL SOLUTION -- STANDARD PROTOCOL OF HYDROGEL EXPOSURE -- INTRODUCTION OF MULTIPLE PLASMIDS INTO E. COLI CELLS USINGTHE HYDROGEL EXPOSURE METHOD -- PLASMID STABILITY -- NUMBER OF PLASMIDS INTRODUCED INTO EACH PENETRATIONINTERMEDIATEUSING THE HYDROGEL EXPOSURE METHOD -- PREDICTED STRUCTURE OF A PENETRATION-INTERMEDIATE -- RESULTS -- INTRODUCTION OF MULTIPLE PLASMIDS INTO E. COLI USINGTHE HYDROGELEXPOSURE METHOD -- PLASMID STABILITY -- NUMBER OF PLASMIDS INTRODUCED INTO THE PENETRATIONINTERMEDIATEUSING THE HYDROGEL EXPOSURE METHOD -- PREDICTED STRUCTURE OF THE PENETRATION-INTERMEDIATE -- CONCLUSION -- REFERENCES.
|
505 |
8 |
|
|a PREVENTION AND DETECTION OF ASBESTOSRELATEDDISEASES IN FINLAND -- ABSTRACT -- USE OF ASBESTOS AND EXPOSURE TO ASBESTOS -- Monitoring the Health Situation of those Who Have Been Exposedto Asbestos -- DISEASES CAUSED BY ASBESTOS AND MORTALITY FROM ASBESTOSRELATEDDISEASES -- Lung Cancer -- Mesothelioma -- Asbestosis -- Pleural Diseases -- THE ASBESTOS EPIDEMIC -- IS IT OVER? -- Early Lung Cancer Diagnostics -- Mesothelioma Panel -- Expert Groups in Pneumoconiosis Diseases -- Registered Asbestos-Related Diseases -- INTERNATIONAL COLLABORATION -- CONCLUSION -- BIBLIOGRAPHY -- AUTOANTIBODY PROFILES OF AN ASBESTOSEXPOSEDPOPULATION -- ABSTRACT -- INTRODUCTION -- AMPHIBOLE ASBESTOS CONTAMINATION INLIBBY, MT -- MATERIALS AND METHODS -- Sample and Data Collection -- Detection of Serum Autoantibodies -- Addressable Laser Bead Immunosorbent Assay (ALBIA) -- Quantification of IgM Rheumatoid factor (RF), Anti-Cyclic CitrullinatedPeptide (CCP), Topo I, and Histone by ELISA -- Cell-Based ELISA for Anti-Fibroblast Antibodies -- Statistical Analysis -- RESULTS -- Frequency of Antinuclear Antibodies -- Autoantibody Characterization -- IgM RF and Anti-CCP Frequency -- Correlation of Autoantibodies with Extent of Exposure and ARD -- Presence of Antibodies to Fibroblasts -- DISCUSSION -- CONCLUSION -- ACKNOWLEDGEMENTS -- REFERENCES -- EPIDEMIOLOGY OF MESOTHELIOMA:THE ROLE OF ASBESTOS -- ABSTRACT -- DEFINITION -- DESCRIPTIVE EPIDEMIOLOGY OF MESOTHELIOMA -- Incidence -- Mortality -- Survival -- Temporal Trends -- Geographic Distribution -- ETIOLOGICAL ROLE OF ASBESTOS AND OTHER FIBERS -- Asbestos -- Other Mineral Fibers Implicated in the Etiopathogenesis of Mesotheliomas -- Duration and Intensity of Exposure to Asbestos and Dose-Response Relation -- Occupational Exposure -- a) Direct Occupational -- b) Indirect Occupational -- c) Environmental Occupational.
|
505 |
8 |
|
|a DESCRIPTION OF TYPES OF EXPOSURE AND RISK IN VARIOUSOCCUPATIONAL SECTORS -- Production of Asbestos Cement -- Insulation and Maintenance Activities of Insulated Industrial Plants -- Construction, Maintenance, Restoration and Repair of Ships -- Construction, Maintenance, Restoration and Repair of Railway Carriages -- Personnel Travelling in Means of Transportation Insulated with Asbestos:Ships and Trains -- Industrial and Civilian Construction Work -- Textile Sector -- Installation and Repair of Lifts -- ENVIRONMENTAL EXPOSURE -- Urban Environment -- CONTRIBUTION OF THE EPIDEMIOLOGY OFMESOTHELIOMA TO PUBLIC HEALTH INITIATIVES -- Environmental Reclamation and Identification of Groups at Risk -- Prevention of the Asbestos Pathology in Developing Countries -- REFERENCES -- ASBESTOS LITIGATION: PROSPECTSFOR LEGISLATIVE RESOLUTION* -- ABSTRACT -- SCOPE OF LITIGATION -- PROCEDURAL IMPROVISATION -- POLICY ALTERNATIVES -- Status Quo -- Changes in Tort Law -- Medical Criteria -- Administrative System -- THE TRUST FUND APPROACH -- Funding Adequacy -- Compensation Adequacy -- Diagnostic Categories -- Disputed Categories -- The Tobacco Question -- Diagnostic Quality Control -- Transition Issues -- Pending Cases -- Pending Settlements -- Funding Schedule -- SUNSET -- REFERENCES -- THE EFFICIENCY OF THE CUSCORE TEST ASCOMPARED TO THAT APPLIED TO SMR INDETECTION OF A CARCINOGENIC EXPOSURE -- INTRODUCTION -- BACKGROUND -- THE TIME INTERVAL BETWEEN EVENTS -- THE CUSCORE TEST -- THE EFFICIENCY OF THE CUSCORE TEST IN ACONCRETE EXAMPLE -- IMPROVING THE TEST EFFICIENCY -- REFERENCES -- RETROPERITONEAL FIBROSIS -- A NEW ASBESTOSRELATEDDISEASE -- ABSTRACT -- INTRODUCTION -- HISTORY AND EPIDEMIOLOGY -- CLINICAL PICTURE AND TREATMENT -- AETIOLOGY -- RETROPERITONEAL FIBROSIS AND ASBESTOS EXPOSURE -- RETROPERITONEAL AND PLEURAL FIBROSIS -- CONCLUSIONS.
|
505 |
8 |
|
|a ENDEMIC PLEURAL PLAQUES AND MESOTHELIOMASIN NORTHERN GREECE -- INTRODUCTION -- METHODS AND RESULTS -- 1st Study Phase (1988-1990) -- X-ray Study -- Environmental Study -- A. Petrologic Study -- B. Air Contamination Study -- 2nd Study Phase (2003) -- DISCUSSION -- CONCLUSION -- REFERENCES -- IMMUNOLOGICAL EFFECTS OF ASBESTOS -- INTRODUCTION -- TEMPORARY HIGH-DOSE EXPOSURE19 -- CONTINUOUS LOW-DOSE EXPOSURE20 -- CHARACTERISTICS OF CONT. EXP. MT-2 CELLS -- CLINICAL TRANSLATION -- FUTURE INVESTIGATIONS -- ACKNOWLEDGEMENT -- REFERENCES -- INDEX.
|
650 |
|
0 |
|a Asbestos
|x Toxicology.
|
650 |
|
0 |
|a Lungs
|x Dust diseases.
|
650 |
|
0 |
|a Environmentally induced diseases.
|
650 |
|
7 |
|a MEDICAL
|x Toxicology.
|2 bisacsh
|
650 |
|
7 |
|a Asbestos
|x Toxicology
|2 fast
|
650 |
|
7 |
|a Environmentally induced diseases
|2 fast
|
650 |
|
7 |
|a Lungs
|x Dust diseases
|2 fast
|
700 |
1 |
|
|a Soto, Antonio,
|d 1961-
|1 https://id.oclc.org/worldcat/entity/E39PCjHXDbfJcfDTPY6jQBFGBP
|
700 |
1 |
|
|a Salazar, Gael.
|
758 |
|
|
|i has work:
|a Asbestos (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCGF97wX7P6BrHJxwvPyC43
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
776 |
0 |
8 |
|i Print version:
|t Asbestos.
|d New York : Nova Biomedical Books, ©2009
|z 9781606920534
|w (DLC) 2009010496
|w (OCoLC)316736629
|
830 |
|
0 |
|a Environmental health (Nova Science Publishers)
|
856 |
4 |
0 |
|u https://ebookcentral.proquest.com/lib/holycrosscollege-ebooks/detail.action?docID=3019084
|y Click for online access
|
903 |
|
|
|a EBC-AC
|
994 |
|
|
|a 92
|b HCD
|